Form 4: Natural Alternatives International Director Alan G. Dunn Receives Stock Grant

Sentiment:

SEC Form 4 Filing


Director Alan G. Dunn of Natural Alternatives International Inc. (NAII) was granted 8,000 shares of restricted stock under the company's 2020 Omnibus Incentive Plan.

Summary

  • Alan G. Dunn, a director at Natural Alternatives International Inc. (NAII), received a grant of 8,000 shares of common stock on March 8, 2024.
  • The grant is part of the Issuer's 2020 Omnibus Incentive Plan.
  • The restricted stock vests in three equal installments: one-third on March 7, 2025, one-third on March 7, 2026, and the final third on March 7, 2027.
  • Following the transaction, Dunn directly owns 83,211 shares of common stock.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of a stock grant, which is generally neutral. It indicates continued alignment of the director with the company's interests.

Positives

  • The stock grant aligns the director's interests with the long-term performance of the company.
  • The vesting schedule encourages continued service and commitment from the director.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

Stock grants are a common form of executive compensation in publicly traded companies, aligning management's interests with those of shareholders.

Comparison to Industry Standards

  • Stock grants are a typical component of executive compensation packages in the nutritional supplements industry, similar to companies like Herbalife Nutrition and USANA Health Sciences.
  • The vesting schedule is standard, encouraging long-term commitment from the director, which aligns with industry practices.

Stakeholder Impact

  • The stock grant could have a slightly positive impact on shareholder sentiment, as it aligns the director's interests with the company's performance.
  • Employees may view the grant as a positive sign of the company's commitment to its leadership.

Key Dates

DateDescription
03/08/2024Date of stock grant transaction
03/07/2025Vesting date for the first third (2,667 shares) of the restricted stock
03/07/2026Vesting date for the second third (2,667 shares) of the restricted stock
03/07/2027Vesting date for the final third (2,666 shares) of the restricted stock
03/15/2024Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.